CNBP and breast carcinoma: In breast cancer, mutant p53 up-regulates mevalonate pathway components at least in part through the sterol regulatory element-binding proteins (SREBP) family of transcription factors, and increased mevalonate pathway flux is necessary and sufficient for the mutant p53 phenotype observed in culture (42).